These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 15056469)
1. Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase. Klivenyi P; Calingasan NY; Starkov A; Stavrovskaya IG; Kristal BS; Yang L; Wieringa B; Beal MF Neurobiol Dis; 2004 Apr; 15(3):610-7. PubMed ID: 15056469 [TBL] [Abstract][Full Text] [Related]
2. Cerebral creatine kinase deficiency influences metabolite levels and morphology in the mouse brain: a quantitative in vivo 1H and 31P magnetic resonance study. in 't Zandt HJ; Renema WK; Streijger F; Jost C; Klomp DW; Oerlemans F; Van der Zee CE; Wieringa B; Heerschap A J Neurochem; 2004 Sep; 90(6):1321-30. PubMed ID: 15341516 [TBL] [Abstract][Full Text] [Related]
17. Regulation of striatal preproenkephalin mRNA levels in MPTP-lesioned mice treated with estradiol. D'Astous M; Morissette M; Callier S; Di Paolo T J Neurosci Res; 2005 Apr; 80(1):138-44. PubMed ID: 15723346 [TBL] [Abstract][Full Text] [Related]
18. Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue. Andres RH; Huber AW; Schlattner U; Pérez-Bouza A; Krebs SH; Seiler RW; Wallimann T; Widmer HR Neuroscience; 2005; 133(3):701-13. PubMed ID: 15890457 [TBL] [Abstract][Full Text] [Related]
19. H MRS identifies lactate rise in the striatum of MPTP-treated C57BL/6 mice. Koga K; Mori A; Ohashi S; Kurihara N; Kitagawa H; Ishikawa M; Mitsumoto Y; Nakai M Eur J Neurosci; 2006 Feb; 23(4):1077-81. PubMed ID: 16519673 [TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease. Liu LX; Chen WF; Xie JX; Wong MS Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]